Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07734272

Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative

Conditions: Polycythemia Vera

Sex: All
Healthy volunteers: Yes
Phase: NA
Enrollment: 32
Sponsor: Massachusetts General Hospital

Summary

The purpose of this quality improvement initiative is to explore whether an electronic medical records-based templated progress note for polycythemia vera (PV) in addition to a standard-of-care pharmacist-collaborative ropeginterferon alfa-2b titration service is feasible, acceptable, and appropriate for clinicians who manage PV.

Eligibility Criteria

Inclusion Criteria: \- Hematologists and medical oncologists within the Mass General Brigham network sites who treat at least one patient with PV in their outpatient clinic. Exclusion Criteria: * Clinicians who do not have an outpatient hematology or medical oncology clinic within Mass General Brigham. * Clinicians who do not utilize the EPIC electronic medical record (EMR) System as their method of patient progress note documentation.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07734272). StuddyBuddy aggregates publicly available trial information.